Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial

Figure 4

Kaplan-Meier analysis for all events (a), all cardiac events (b), all cause deaths (c), and rehospitalization (d) between tolvaptan group and carperitide group.

(a)

(b)

(c)

(d)